跳至主要内容
临床试验/NCT07746102
NCT07746102招募中不适用

Assessment of the Impact of Repeated Ischemic Preconditioning Episodes on Hemodynamic and Metabolic Parameters in Patients at Various Stages of Chronic Kidney Disease

Medical University of Lodz2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年7月23日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
2
主要终点
Assessment of changes of parameter: Measurement of SIRT-1 [ng/]

研究概览

简要总结

The aim of our study is to evaluate the impact of repeated episodes of ischemic quenching on changes in blood pressure, heart rate and laboratory parameters of inflammation in patients with kidney diseases. There is credible evidence that intentionally producing periods of ischemia provides protection of the myocardium and blood vessels against subsequent ischemic injury. The examination will be performed during hospitalization in the Department of Nephrology, Hypertension, Transplantology and Internal Diseases and will last 4 days. On the first day, blood pressure will be measured using an automatic blood pressure monitor, radial artery pulse, blood saturation will be measured using a pulse oximeter, and approximately 6 ml of venous blood will be collected from the elbow bend area for laboratory tests. Then, compression of the lower limb below the knee will be performed using a blood pressure cuff. Four 5-minute cycles of inflation and deflation of the cuff will be performed. The pressure on the lower limb will be repeated on the next two days. On the last day of the examination, blood pressure, heart rate and blood saturation will be measured again, and approximately 6 ml of venous blood will be collected again for laboratory tests.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • obtaining the patient's voluntary, informed consent to participate in the experiment,
  • chronic kidney disease in stages G1-G5,
  • women and men over 18 years of age.
  • failure to meet the qualification criteria for participation in the study,
  • consciousness disorders,
  • heart failure (NYHA IV),
  • severe anemia (Hb concentration<8g/dL),
  • features of muscle cell damage (e.g. rhabdomyolysis),
  • peripheral circulation disorders, peripheral vascular diseases.

排除标准

  • 未提供

结局指标

主要结局

Assessment of changes of parameter: Measurement of SIRT-1 [ng/]

时间窗: 7 days

Measurement of SIRT-1 \[ng/\] at the beginning and 7 days

Assessment of changes of parameter blood saturation [%].

时间窗: 7 days

at the beginning and 7 days

Assessment of IL-6

时间窗: 7 days

Measurement of IL-6 \[ng/ml\] at the beginning and 7 days.

Assessment of Blood pressure

时间窗: 7 days

Blood pressure \[mmHg\] will be checked at the beginning and 7 days

Assessment of heart beat/min

时间窗: 7 days

will be checked at the beginning and 7 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Katarzyna Peczek-Bartyzel

Nephrologist

Medical University of Lodz

研究点 (2)

Loading locations...

相似试验

Assessment of the Impact of Repeated Ischemic... | 临床试验